Management of Non-Traumatic Sublingual Bleeding in Elderly Patients

Initial Assessment and Stabilization

• The American Geriatrics Society recommends maintaining continuous pulse oximetry and cardiac monitoring with target heart rate <90 bpm and systolic blood pressure >110 mmHg in elderly patients with sublingual bleeding 1

Urgent Medication History and Laboratory Assessment

• The American Geriatrics Society suggests immediately obtaining a focused medication history for warfarin, DOACs, antiplatelet agents, and NSAIDs in elderly patients with sublingual bleeding, as these medications increase bleeding risk 2, 1, 3
• Essential laboratory tests, including INR, PT, aPTT, and platelet count, must be obtained immediately in patients with sublingual bleeding 1, 4

Anticoagulant Reversal Protocol

• The World Journal of Emergency Surgery recommends administering 4-factor prothrombin complex concentrate at 25-50 IU/kg and 5-10 mg intravenous vitamin K immediately for warfarin reversal in patients with INR ≥2.0 and sublingual bleeding 1, 4, 5
• Idarucizumab 5 g IV should be administered immediately for life-threatening bleeding with dosable plasma dabigatran levels 1, 6
• Andexanet alfa should be administered per protocol for life-threatening bleeding with dosable DOAC levels 1

Monitoring Protocol

• The Journal of the American Geriatrics Society recommends serial monitoring of hemoglobin/hematocrit every 6-12 hours until bleeding is controlled and values stabilize in elderly patients with sublingual bleeding 9
• Serial lactate and base deficit measurements should be performed to assess ongoing bleeding, as lactate >2 mmol/L for >48 hours or base deficit <-6 mEq/L increases mortality risk four-fold 1, 3

Critical Pitfalls to Avoid

• The World Journal of Emergency Surgery advises against relying on normal vital signs to exclude significant bleeding in elderly patients, as they may have blunted catecholamine responses 3
• The Journal of the American Geriatrics Society recommends against using standard 5 mg warfarin starting doses in elderly patients, as they require lower initiation doses due to increased pharmacodynamic response 2, 8

Resumption of Anticoagulation

• The Gut journal recommends resuming anticoagulation after adequate hemostasis is achieved, typically 7-10 days post-bleeding event, balancing thromboembolic risk against recurrent hemorrhage risk 6, 5